Table 5.
Correlations between semantic clustering on CVLT-II and neuropsychological test performance
Trial 1 | Trial 5 | Short-delay | Long-delay | |
---|---|---|---|---|
Controls | ||||
Animal Fluency | –.046 | .246 | .131 | .059 |
TMT-Part B | –.156 | –.027 | –.116 | –.108 |
Stroop Interference | .146 | –.188 | –.151 | –.115 |
naMCI | ||||
Animal Fluency | .184 | –.258 | .253 | .171 |
TMT-Part B | –.104 | –.043 | –.365** | –.271 |
Stroop Interference | –.059 | .297 | –.112 | –.158 |
aMCI | ||||
Animal Fluency | .051 | .161 | .253* | .239* |
TMT-Part B | –.101 | –.235* | –.174 | –.309** |
Stroop Interference | –.034 | –.170 | –.188 | –.316** |
AD | ||||
Animal Fluency | –.099 | .230 | –.057 | .114 |
TMT-Part B | –.158 | –.274 | –.110 | –.084 |
Stroop Interference | –.026 | –.405 | .398 | .065 |
Note. CVLT-II = California Verbal Learning Test-II (raw chance-adjusted semantic clustering scores: –3 to 9; raw recall scores: 0 to 16; Delis et al., 2000); naMCI = nonamnestic mild cognitive impairment; aMCI = amnestic mild cognitive impairment; AD = Alzheimer's disease; TMT = Trail Making Test.
small effect size.
medium effect size.